Encompass Health (EHC) EPS (Weighted Average and Diluted) (2009 - 2026)

Encompass Health has reported EPS (Weighted Average and Diluted) for 18 years, with the latest figure at $1.93 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 30.41% year-over-year to $1.93; the trailing twelve-month figure through Mar 2026 stood at $6.0 (up 23.97% YoY), and the FY2025 full-year result was $5.55, up 23.61% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $1.93, up from $1.44 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $1.93 in Q1 2026, with the low at $0.45 in Q3 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.06 across 5 years, with a median of $1.06 in 2024.
• Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) sank 40.79% — and 2023, when it soared 88.89%.
• Encompass Health's EPS (Weighted Average and Diluted) stood at $0.9 in 2022, then climbed by 7.78% to $0.97 in 2023, then advanced by 21.65% to $1.18 in 2024, then advanced by 22.03% to $1.44 in 2025, then soared by 34.03% to $1.93 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $1.93 (Q1 2026), $1.44 (Q4 2025), and $1.24 (Q3 2025), per Business Quant data.